These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28148699)

  • 21. Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis.
    Yeo C; Kaushal S; Lim B; Syn N; Oo AM; Rao J; Koura A; Yeo D
    Obes Rev; 2019 Dec; 20(12):1759-1770. PubMed ID: 31468681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
    Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
    Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL?
    Ruoff G; Edwards NL
    Postgrad Med; 2016 Sep; 128(7):706-15. PubMed ID: 27558643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.
    Janssen CA; Oude Voshaar MAH; Ten Klooster PM; Vonkeman HE; van de Laar MAFJ
    Clin Rheumatol; 2019 Aug; 38(8):2233-2239. PubMed ID: 31030363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.
    Desai RJ; Franklin JM; Spoendlin-Allen J; Solomon DH; Danaei G; Kim SC
    PLoS One; 2018; 13(2):e0193622. PubMed ID: 29489919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.
    Levy GD; Rashid N; Niu F; Cheetham TC
    J Rheumatol; 2014 May; 41(5):955-62. PubMed ID: 24692523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
    Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
    RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What do I need to know about gout?
    Becker MA; Ruoff GE
    J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study.
    Latourte A; Soumaré A; Bardin T; Perez-Ruiz F; Debette S; Richette P
    Ann Rheum Dis; 2018 Mar; 77(3):328-335. PubMed ID: 28754803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is tea consumption associated with the serum uric acid level, hyperuricemia or the risk of gout? A systematic review and meta-analysis.
    Zhang Y; Cui Y; Li XA; Li LJ; Xie X; Huang YZ; Deng YH; Zeng C; Lei GH
    BMC Musculoskelet Disord; 2017 Feb; 18(1):95. PubMed ID: 28245834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout.
    Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu EQ; Tawk R; Liu J; Shi L
    QJM; 2013 Aug; 106(8):721-9. PubMed ID: 23620537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Urate and Recurrent Gout.
    McCormick N; Yokose C; Challener GJ; Joshi AD; Tanikella S; Choi HK
    JAMA; 2024 Feb; 331(5):417-424. PubMed ID: 38319333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.
    Li X; Meng X; Timofeeva M; Tzoulaki I; Tsilidis KK; Ioannidis JP; Campbell H; Theodoratou E
    BMJ; 2017 Jun; 357():j2376. PubMed ID: 28592419
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
    Fleischmann R; Kerr B; Yeh LT; Suster M; Shen Z; Polvent E; Hingorani V; Quart B; Manhard K; Miner JN; Baumgartner S;
    Rheumatology (Oxford); 2014 Dec; 53(12):2167-74. PubMed ID: 24509406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.
    Stamp L; Morillon MB; Taylor WJ; Dalbeth N; Singh JA; Lassere M; Christensen R
    Semin Arthritis Rheum; 2018 Oct; 48(2):293-301. PubMed ID: 29566967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uric acid fluctuation had no effect on renal function among gout patients.
    Shen J; Zhu J; Si S; Fu Y; Mo M; Xin X; Shao B; Shen Y; Wang S; Wu H; Yu Y
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1833-1839. PubMed ID: 32675011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
    Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
    Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.
    Dalbeth N; Phipps-Green A; Frampton C; Neogi T; Taylor WJ; Merriman TR
    Ann Rheum Dis; 2018 Jul; 77(7):1048-1052. PubMed ID: 29463518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Urate Monitoring Among Older Adults With Gout: Initiating Urate-Lowering Therapy in Ontario, Canada.
    Kwok TSH; Kuriya B; Hawker G; Li P; Choy G; Widdifield J
    Arthritis Care Res (Hoboken); 2023 Dec; 75(12):2463-2471. PubMed ID: 37248652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
    Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
    Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.